Your browser doesn't support javascript.
loading
Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis.
de Lavallade, Hugues; Apperley, Jane F; Khorashad, Jamshid S; Milojkovic, Dragana; Reid, Alistair G; Bua, Marco; Szydlo, Richard; Olavarria, Eduardo; Kaeda, Jaspal; Goldman, John M; Marin, David.
Affiliation
  • de Lavallade H; Department of Haematology, Imperial College London, Du Cane Rd, London W12 0NN, United Kingdom.
J Clin Oncol ; 26(20): 3358-63, 2008 Jul 10.
Article in En | MEDLINE | ID: mdl-18519952

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Bone Marrow Cells / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2008 Document type: Article Affiliation country: United kingdom Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Bone Marrow Cells / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2008 Document type: Article Affiliation country: United kingdom Country of publication: United States